MedPath

The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta

Not Applicable
Conditions
Placenta Previa Accreta
Placenta Previa
Registration Number
NCT02590484
Lead Sponsor
Minia University
Brief Summary

Placenta previa and placenta accrete carry significant maternal and fetal morbidity and mortality. Several techniques have been described in the literature for controlling massive bleeding associated with placenta previa cesarean sections. The aim of this study is to evaluate the efficacy and safety of the use of the cervix as a natural tamponade in controlling postpartum hemorrhage caused by placenta previa and placenta previa accreta.

Detailed Description

Background: Placenta previa and placenta accrete carry significant maternal and fetal morbidity and mortality. The maternal mortality in women with placenta accreta may reach as high as 7-10%. Several techniques have been described in the literature for controlling massive bleeding associated with placenta previa cesarean sections, including uterine packing with gauze, balloon tamponades, the B-Lynch suture, insertion of parallel vertical compression sutures, a square suturing technique and embolization or ligation of the uterine and internal iliac arteries, but there is a wide variation in the success rate of these maneuvers. In a case report, Dawlatly et al. (2007) described a simple technique of suturing an inverted lip of the cervix over the bleeding placental bed that was successful in controlling the bleeding, saving the patient's life, and preserving her uterus.

The objective of this trial is to evaluate the safety and efficacy of the use of this Dawlatly stitch as a natural tamponade for controlling postpartum haemorrhage in cases of placenta previa and/ or placenta previa accreta.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  1. All participating women had one or more previous cesarean deliveries.
  2. were diagnosed with placenta previa and/ or placenta previa accreta by ultrasound. When the ultrasound result was not conclusive for placenta accreta, MRI was performed.
  3. All participating women desired to preserve their fertility
  4. Patients with focal (partial) placenta previa accreta/ placenta previa.
Exclusion Criteria
  1. placenta percreta.
  2. diffuse placenta accreta or increta.
  3. uncontrollable postpartum hemorrhage.

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Successful control of postpartum haemorrhage (PPH)Intra-operative and up to 24 hours postpartum

Control of PPH and vaginal bleeding after employing the technique

Number of cases undergoing hysterectomy to control PPHIntra-operative and up to 24 hours postpartum

Failure of the technique to stop PPH and need for hysterectomy to stop the bleeding

Incidence of complicationsshort term (intraoperative and up to 6 weeks postpartum)-long term:up to 2 years postpartum
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Obstetrics and Gynaecology, Minia University Hospital

🇪🇬

Minia, Egypt

© Copyright 2025. All Rights Reserved by MedPath